공황장애와 도파민 수송체 유전자 다형성과의 연관성

참고문헌 (35)

1. Weissman MM, "The cross-national epidemiology of panic disorder.", 54, pp.305~ (1994)
2. Knowles JA, "Panic disorder and agoraphobia.", pp.383~404 (1995), Washington DC: American Psychiatric Press
3. Neale MC, "Eaves LJ. Panic disorder in women", pp.397~406
4. Crowe RR, "Candidate gene study of eight GABAA receptor subunits in panic disorder.", 154, pp.1096~1100 (1997)
5. Hamilton SP, "Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder.", 9, pp.1~6 (1999)
6. Ishiguro H, "An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population.", 51, pp.333~335 (1997)
7. Kato T, "Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder.", 67, pp.401~405 (1996)
8. Ohara K, "The genes encoding the 5HT1D alpha and 5HT1D beta receptors are unchanged in patients with panic disorder.", 39, pp.5~10 (1996)
9. Steinlein OK, "Neuronal nicotinic acetylcholine receptor alpha 4 subunit(CHRNA4) and panic disorder: an association study.", 74, pp.199~201 (1997)
10. Wang Z, "Possible association of a cholecystokinin promotor polymorphism(CCK_36CT) with panic disorder.", 81, pp.228~234 (1998)
11. Knowles JA, "Results of a genomewide genetic screen for panic disorder.", 81, pp.139~147 (1998)
12. Roy-Byrne PP, "Linnoila M, Post RM. Plasma HVA and anxiety in patients with panic disorder.", lin(ila m), pp.847~849
13. Schneider P, "Hoey H. Plasma biogenic amine levels in agoraphobia with panic attacks. Pharmacopsychiatry 1987", pp.102~104
14. Westberg P, "Modigh K. Cerebrospinal fluid levels of monoamine metabolites in panic disorder. Psychiatry Res. 1991", pp.243~251
15. Johnson MR, "Ballenger JC. Plasma and CSF HVA levels in panic patients with comorbid social phobia. Biol Psychiatry 1994", pp.425~427
16. Moreno AG, "von Frenkell R. Dopaminergic function in panic disorder comparison with major and minor depression. Biol Psychiatry 1992", pp.1004~1011
17. Anthony JC, "Petronis KR. Epidemiologic evidence on cocaine use and panic attacks. Am J Epidemiol 1989", pp.543~549
18. Crawford F, "Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorder.", 60, pp.332~334 (1995)
19. Cichon S, "Identification of two novel polymorphisms and a rare deletion variant in the human dopamine D4 receptor gene.", 5, pp.97~103 (1995)
20. Espejo EF, "Espejo EF. Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res 1991", pp.243~251
21. Steiner H, "D3 dopamine receptor-deficient mouse: evidence for reduced anxiety.", 63, pp.137~141 (1998)
22. Bir, "Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats.", 31, pp.281~285 (1997)
23. Benjamin J, "Dopamine D4 receptor polymorphism associated with panic disorder.", 74, pp.613~ (1997)
24. Hamilton SP, "Investigation of DRD4 and DAT polymorphisms for genetic linkage or association to panic disorder.", 96, pp.324~330 (2000)
25. Lim SW, "Association between panic disorder and dopamine D2 receptor TaqI polymorphism.", 2(1), pp.45~49 (2006)
26. Vandenbergh DJ, "Human dopamine transporter gene(DAT1) maps to chromosome 5p15.3 and displays VNTR.", pp.1104~1106, Griffin CA
27. Fuke S, "The VNTR polymorphism of the human dopamine transporter(DAT1) gene effects gene expression.", 1, pp.152~156 (2001)
28. Jacobson L, "Prediction of dopamine transporter binding availability by genotype: a preliminary report.", 157, pp.1700~1703 (2000)
29. Shin DW, "Association between attention deficit hyperactivity disorder and dopamine transporter gene(DAT1) polymorphism in Korean.", 41(4), pp.612~618 (2002)
30. IPT SPECT on response to methylphenidate treatment in attention deficit hyperactivity disorder., , 2004, 151~158
31. Mitchelle RJ, "Distribution of the 3' VNTR polymorphism in the human dopamine transporter gene in world populations.", 72, pp.295~304 (2000)
32. Nakatome M, "Amplification of DAT1(human dopamine transporter gene) 3' variable region in the Japanese population.", 45, pp.262~265 (1995)
33. Nakatome M, "Genetic polymorphism of the 3' VNTR region of the human dopaminergic function gene DAT1(human dopamine transporter gene) in the Mongolian population.", 69, pp.509~515 (1996)
34. Oliveros SC, "et al. Panic attacks in schizophrenia Br J Psychiatry 1991", pp.436~437
35. Chu E, "7-OH-DPAT-induced inhibition of norepinephrine release in PC12 cells.", 70, pp.130~139 (2004)

관련 논문AI추천